Zdravka medarova

Zdravka medarova

Company: TransCode Therapeutics

Job title: cto

Seminars:

siRNA-Based Cancer Immunotherapy 12:00 pm

Unveiling TTX: a novel platform for nucleic acid delivery to tumors TTX-siPDL1 is an RNAi checkpoint inhibitor with efficacy in preclinical PDAC Demonstrating how TTX-siPDL1 activity relies on both tumor cell and TAM targetingRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.